AirSculpt Technologies, Inc. (AIRS)
- Previous Close
5.82 - Open
5.76 - Bid 5.66 x 100
- Ask 5.84 x 100
- Day's Range
5.76 - 5.82 - 52 Week Range
2.92 - 8.30 - Volume
1,238 - Avg. Volume
73,542 - Market Cap (intraday)
334.898M - Beta (5Y Monthly) 1.65
- PE Ratio (TTM)
-- - EPS (TTM)
-0.06 - Earnings Date Nov 7, 2024 - Nov 11, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date Aug 25, 2022
- 1y Target Est
3.92
AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. The company offers AirSculpt, a next-generation body contouring procedure that removes unwanted fat and tightens skin in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool. In addition, it provides fat removal procedures across treatment areas, such as the stomach, back, and buttocks; and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips, or other areas. The company's body contouring procedures also include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. It operates various centers. The company was founded in 2012 and is headquartered in Miami Beach, Florida.
elitebodysculpture.com346
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: AIRS
View MorePerformance Overview: AIRS
Trailing total returns as of 10/17/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AIRS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AIRS
View MoreValuation Measures
Market Cap
327.70M
Enterprise Value
418.29M
Trailing P/E
227.18
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.73
Price/Book (mrq)
3.94
Enterprise Value/Revenue
2.21
Enterprise Value/EBITDA
21.85
Financial Highlights
Profitability and Income Statement
Profit Margin
-1.77%
Return on Assets (ttm)
2.45%
Return on Equity (ttm)
-4.11%
Revenue (ttm)
193.02M
Net Income Avi to Common (ttm)
-3.42M
Diluted EPS (ttm)
-0.06
Balance Sheet and Cash Flow
Total Cash (mrq)
9.87M
Total Debt/Equity (mrq)
118.17%
Levered Free Cash Flow (ttm)
3.92M